PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

Jennifer L Bishop, Alexander Sio, Arkhjamil Angeles, Morgan E Roberts, Arun A Azad, Kim N Chi, Amina Zoubeidi

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)234-242
Number of pages9
JournalOncotarget
Volume6
Issue number1
Publication statusPublished - 2015
Externally publishedYes

Cite this

Bishop, J. L., Sio, A., Angeles, A., Roberts, M. E., Azad, A. A., Chi, K. N., & Zoubeidi, A. (2015). PD-L1 is highly expressed in Enzalutamide resistant prostate cancer. Oncotarget, 6(1), 234-242.
Bishop, Jennifer L ; Sio, Alexander ; Angeles, Arkhjamil ; Roberts, Morgan E ; Azad, Arun A ; Chi, Kim N ; Zoubeidi, Amina. / PD-L1 is highly expressed in Enzalutamide resistant prostate cancer. In: Oncotarget. 2015 ; Vol. 6, No. 1. pp. 234-242.
@article{6079499245c84bcaafa8f78ce84e507e,
title = "PD-L1 is highly expressed in Enzalutamide resistant prostate cancer",
author = "Bishop, {Jennifer L} and Alexander Sio and Arkhjamil Angeles and Roberts, {Morgan E} and Azad, {Arun A} and Chi, {Kim N} and Amina Zoubeidi",
year = "2015",
language = "English",
volume = "6",
pages = "234--242",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "1",

}

Bishop, JL, Sio, A, Angeles, A, Roberts, ME, Azad, AA, Chi, KN & Zoubeidi, A 2015, 'PD-L1 is highly expressed in Enzalutamide resistant prostate cancer' Oncotarget, vol. 6, no. 1, pp. 234-242.

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer. / Bishop, Jennifer L; Sio, Alexander; Angeles, Arkhjamil; Roberts, Morgan E; Azad, Arun A; Chi, Kim N; Zoubeidi, Amina.

In: Oncotarget, Vol. 6, No. 1, 2015, p. 234-242.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

AU - Bishop, Jennifer L

AU - Sio, Alexander

AU - Angeles, Arkhjamil

AU - Roberts, Morgan E

AU - Azad, Arun A

AU - Chi, Kim N

AU - Zoubeidi, Amina

PY - 2015

Y1 - 2015

M3 - Article

VL - 6

SP - 234

EP - 242

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 1

ER -

Bishop JL, Sio A, Angeles A, Roberts ME, Azad AA, Chi KN et al. PD-L1 is highly expressed in Enzalutamide resistant prostate cancer. Oncotarget. 2015;6(1):234-242.